Global Pneumonia Therapeutics Market Size study & Forecast, by Therapeutics (Prevention Vaccines and Treatment Drugs), by Distribution Channel (Hospitals, Pharmaceutical Stores, and Others), and by Age Group (Pediatric, Adult, and Geriatric) and Regional Analysis, 2022-2029
Global Pneumonia Therapeutics Market is valued approximately USD 13.24 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.5% over the forecast period 2022-2029. Pneumonia is a type of acute respiratory infection that inflames the air sacs in one or both lungs caused by bacteria, viruses, or fungi. The signs and symptoms of Pneumonia include cough, with greenish, yellow, and bloody mucus, fever, sweating, shortness of breath, rapid, shallow breathing, and stabbing chest pain among others. The increasing incidences of pneumonia and growing unmet clinical needs as well as strategic initiatives from leading market players are key factors accelerating the market growth.
According to UNICEF – as of 2019, globally around 700,000 children under five lost their lives every year, accounting for around 2,000 deaths every day. In addition, South Asia (2,500 cases per 100,000 children) is the most affected region followed by West and Central Africa (1,620 cases per 100,000 children). Also, rising healthcare spending in developing regions and growing number of R&D activities in pharmaceuticals sector would create lucrative growth prospectus for the market over the forecast period. However, a high treatment cost and lack of awareness towards preventive vaccines impede the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Pneumonia Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region in terms of revenue due to presence of leading pharmaceutical giants as well as availability of robust healthcare infrastructure in the region. Whereas Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric population and increasing prevalence of pneumonia in children in the region.
Major market player included in this report are:
Abbott Laboratories
Bayer AG
Eli Lilly & Company
GlaxoSmithKline PLC.
Lupin Pharmaceuticals, Inc.
Merck KGAA
Novartis AG
Pfizer, Inc.
Sanofi S.A.
Teva Pharmaceuticals Industries Limited.
Recent Developments in the Market:
In December 2020, India based Serum Institute of India launched first indigenous vaccine for pneumonia. The new vaccines would be provided for children throughout the world with the help of UNICEF network.
In July 2021, US based Merck received the U.S. Food and Drug Administration (FDA) approval for its new VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) intended for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in adults 18 years of age and older.
Global Pneumonia Therapeutics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Therapeutics, Distribution Channel, Age Group, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Therapeutics
Prevention Vaccines
Treatment Drugs
By Distribution Channel
Hospitals
Pharmaceutical Stores
Other
By Age Group
Pediatric
Adult
Geriatric
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
According to UNICEF – as of 2019, globally around 700,000 children under five lost their lives every year, accounting for around 2,000 deaths every day. In addition, South Asia (2,500 cases per 100,000 children) is the most affected region followed by West and Central Africa (1,620 cases per 100,000 children). Also, rising healthcare spending in developing regions and growing number of R&D activities in pharmaceuticals sector would create lucrative growth prospectus for the market over the forecast period. However, a high treatment cost and lack of awareness towards preventive vaccines impede the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Pneumonia Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region in terms of revenue due to presence of leading pharmaceutical giants as well as availability of robust healthcare infrastructure in the region. Whereas Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric population and increasing prevalence of pneumonia in children in the region.
Major market player included in this report are:
Abbott Laboratories
Bayer AG
Eli Lilly & Company
GlaxoSmithKline PLC.
Lupin Pharmaceuticals, Inc.
Merck KGAA
Novartis AG
Pfizer, Inc.
Sanofi S.A.
Teva Pharmaceuticals Industries Limited.
Recent Developments in the Market:
In December 2020, India based Serum Institute of India launched first indigenous vaccine for pneumonia. The new vaccines would be provided for children throughout the world with the help of UNICEF network.
In July 2021, US based Merck received the U.S. Food and Drug Administration (FDA) approval for its new VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) intended for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in adults 18 years of age and older.
Global Pneumonia Therapeutics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Therapeutics, Distribution Channel, Age Group, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Therapeutics
Prevention Vaccines
Treatment Drugs
By Distribution Channel
Hospitals
Pharmaceutical Stores
Other
By Age Group
Pediatric
Adult
Geriatric
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Pneumonia Therapeutics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Pneumonia Therapeutics Market, by Therapeutics, 2019-2029 (USD Billion)
1.2.3. Pneumonia Therapeutics Market, by Distribution Channel, 2019-2029 (USD Billion)
1.2.4. Pneumonia Therapeutics Market, by Age Group, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL PNEUMONIA THERAPEUTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL PNEUMONIA THERAPEUTICS MARKET DYNAMICS
3.1. Pneumonia Therapeutics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidences of Pneumonia
3.1.1.2. Growing unmet clinical needs
3.1.1.3. Strategic initiatives from leading market players.
3.1.2. Market Challenges
3.1.2.1. High treatment cost.
3.1.2.2. Lack of awareness towards preventive vaccines.
3.1.3. Market Opportunities
3.1.3.1. Rising healthcare spending in developing regions.
3.1.3.2. Growing number of R&D activities in pharmaceuticals sector.
CHAPTER 4. GLOBAL PNEUMONIA THERAPEUTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL PNEUMONIA THERAPEUTICS MARKET, BY THERAPEUTICS
6.1. Market Snapshot
6.2. Global Pneumonia Therapeutics Market by Therapeutics, Performance - Potential Analysis
6.3. Global Pneumonia Therapeutics Market Estimates & Forecasts by Therapeutics 2019-2029 (USD Billion)
6.4. Pneumonia Therapeutics Market, Sub Segment Analysis
6.4.1. Prevention Vaccines
6.4.2. Treatment Drugs
CHAPTER 7. GLOBAL PNEUMONIA THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL
7.1. Market Snapshot
7.2. Global Pneumonia Therapeutics Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Pneumonia Therapeutics Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
7.4. Pneumonia Therapeutics Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Pharmaceutical Stores
7.4.3. Others
CHAPTER 8. GLOBAL PNEUMONIA THERAPEUTICS MARKET, BY AGE GROUP
8.1. Market Snapshot
8.2. Global Pneumonia Therapeutics Market by Age Group, Performance - Potential Analysis
8.3. Global Pneumonia Therapeutics Market Estimates & Forecasts by Age Group 2019-2029 (USD Billion)
8.4. Pneumonia Therapeutics Market, Sub Segment Analysis
8.4.1. Pediatric
8.4.2. Adult
8.4.3. Geriatric
CHAPTER 9. GLOBAL PNEUMONIA THERAPEUTICS MARKET, REGIONAL ANALYSIS
9.1. Pneumonia Therapeutics Market, Regional Market Snapshot
9.2. North America Pneumonia Therapeutics Market
9.2.1. U.S. Pneumonia Therapeutics Market
9.2.1.1. Therapeutics breakdown estimates & forecasts, 2019-2029
9.2.1.2. Distribution Channel breakdown estimates & forecasts, 2019-2029
9.2.1.3. Age Group breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Pneumonia Therapeutics Market
9.3. Europe Pneumonia Therapeutics Market Snapshot
9.3.1. U.K. Pneumonia Therapeutics Market
9.3.2. Germany Pneumonia Therapeutics Market
9.3.3. France Pneumonia Therapeutics Market
9.3.4. Spain Pneumonia Therapeutics Market
9.3.5. Italy Pneumonia Therapeutics Market
9.3.6. Rest of Europe Pneumonia Therapeutics Market
9.4. Asia-Pacific Pneumonia Therapeutics Market Snapshot
9.4.1. China Pneumonia Therapeutics Market
9.4.2. India Pneumonia Therapeutics Market
9.4.3. Japan Pneumonia Therapeutics Market
9.4.4. Australia Pneumonia Therapeutics Market
9.4.5. South Korea Pneumonia Therapeutics Market
9.4.6. Rest of Asia Pacific Pneumonia Therapeutics Market
9.5. Latin America Pneumonia Therapeutics Market Snapshot
9.5.1. Brazil Pneumonia Therapeutics Market
9.5.2. Mexico Pneumonia Therapeutics Market
9.6. Rest of The World Pneumonia Therapeutics Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Abbott Laboratories
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Bayer AG
10.2.3. Eli Lilly & Company
10.2.4. GlaxoSmithKline PLC.
10.2.5. Lupin Pharmaceuticals, Inc.
10.2.6. Merck KGAA
10.2.7. Novartis AG
10.2.8. Pfizer, Inc.
10.2.9. Sanofi S.A.
10.2.10. Teva Pharmaceuticals Industries Limited.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Pneumonia Therapeutics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Pneumonia Therapeutics Market, by Therapeutics, 2019-2029 (USD Billion)
1.2.3. Pneumonia Therapeutics Market, by Distribution Channel, 2019-2029 (USD Billion)
1.2.4. Pneumonia Therapeutics Market, by Age Group, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL PNEUMONIA THERAPEUTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL PNEUMONIA THERAPEUTICS MARKET DYNAMICS
3.1. Pneumonia Therapeutics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidences of Pneumonia
3.1.1.2. Growing unmet clinical needs
3.1.1.3. Strategic initiatives from leading market players.
3.1.2. Market Challenges
3.1.2.1. High treatment cost.
3.1.2.2. Lack of awareness towards preventive vaccines.
3.1.3. Market Opportunities
3.1.3.1. Rising healthcare spending in developing regions.
3.1.3.2. Growing number of R&D activities in pharmaceuticals sector.
CHAPTER 4. GLOBAL PNEUMONIA THERAPEUTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL PNEUMONIA THERAPEUTICS MARKET, BY THERAPEUTICS
6.1. Market Snapshot
6.2. Global Pneumonia Therapeutics Market by Therapeutics, Performance - Potential Analysis
6.3. Global Pneumonia Therapeutics Market Estimates & Forecasts by Therapeutics 2019-2029 (USD Billion)
6.4. Pneumonia Therapeutics Market, Sub Segment Analysis
6.4.1. Prevention Vaccines
6.4.2. Treatment Drugs
CHAPTER 7. GLOBAL PNEUMONIA THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL
7.1. Market Snapshot
7.2. Global Pneumonia Therapeutics Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Pneumonia Therapeutics Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
7.4. Pneumonia Therapeutics Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Pharmaceutical Stores
7.4.3. Others
CHAPTER 8. GLOBAL PNEUMONIA THERAPEUTICS MARKET, BY AGE GROUP
8.1. Market Snapshot
8.2. Global Pneumonia Therapeutics Market by Age Group, Performance - Potential Analysis
8.3. Global Pneumonia Therapeutics Market Estimates & Forecasts by Age Group 2019-2029 (USD Billion)
8.4. Pneumonia Therapeutics Market, Sub Segment Analysis
8.4.1. Pediatric
8.4.2. Adult
8.4.3. Geriatric
CHAPTER 9. GLOBAL PNEUMONIA THERAPEUTICS MARKET, REGIONAL ANALYSIS
9.1. Pneumonia Therapeutics Market, Regional Market Snapshot
9.2. North America Pneumonia Therapeutics Market
9.2.1. U.S. Pneumonia Therapeutics Market
9.2.1.1. Therapeutics breakdown estimates & forecasts, 2019-2029
9.2.1.2. Distribution Channel breakdown estimates & forecasts, 2019-2029
9.2.1.3. Age Group breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Pneumonia Therapeutics Market
9.3. Europe Pneumonia Therapeutics Market Snapshot
9.3.1. U.K. Pneumonia Therapeutics Market
9.3.2. Germany Pneumonia Therapeutics Market
9.3.3. France Pneumonia Therapeutics Market
9.3.4. Spain Pneumonia Therapeutics Market
9.3.5. Italy Pneumonia Therapeutics Market
9.3.6. Rest of Europe Pneumonia Therapeutics Market
9.4. Asia-Pacific Pneumonia Therapeutics Market Snapshot
9.4.1. China Pneumonia Therapeutics Market
9.4.2. India Pneumonia Therapeutics Market
9.4.3. Japan Pneumonia Therapeutics Market
9.4.4. Australia Pneumonia Therapeutics Market
9.4.5. South Korea Pneumonia Therapeutics Market
9.4.6. Rest of Asia Pacific Pneumonia Therapeutics Market
9.5. Latin America Pneumonia Therapeutics Market Snapshot
9.5.1. Brazil Pneumonia Therapeutics Market
9.5.2. Mexico Pneumonia Therapeutics Market
9.6. Rest of The World Pneumonia Therapeutics Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Abbott Laboratories
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Bayer AG
10.2.3. Eli Lilly & Company
10.2.4. GlaxoSmithKline PLC.
10.2.5. Lupin Pharmaceuticals, Inc.
10.2.6. Merck KGAA
10.2.7. Novartis AG
10.2.8. Pfizer, Inc.
10.2.9. Sanofi S.A.
10.2.10. Teva Pharmaceuticals Industries Limited.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Pneumonia Therapeutics Market, report scope
TABLE 2. Global Pneumonia Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Pneumonia Therapeutics Market estimates & forecasts by Therapeutics 2019-2029 (USD Billion)
TABLE 4. Global Pneumonia Therapeutics Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
TABLE 5. Global Pneumonia Therapeutics Market estimates & forecasts by Age Group 2019-2029 (USD Billion)
TABLE 6. Global Pneumonia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Pneumonia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Pneumonia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Pneumonia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Pneumonia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Pneumonia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Pneumonia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Pneumonia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Pneumonia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Pneumonia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Pneumonia Therapeutics Market
TABLE 71. List of primary sources, used in the study of global Pneumonia Therapeutics Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Pneumonia Therapeutics Market, report scope
TABLE 2. Global Pneumonia Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Pneumonia Therapeutics Market estimates & forecasts by Therapeutics 2019-2029 (USD Billion)
TABLE 4. Global Pneumonia Therapeutics Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
TABLE 5. Global Pneumonia Therapeutics Market estimates & forecasts by Age Group 2019-2029 (USD Billion)
TABLE 6. Global Pneumonia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Pneumonia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Pneumonia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Pneumonia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Pneumonia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Pneumonia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Pneumonia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Pneumonia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Pneumonia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Pneumonia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Pneumonia Therapeutics Market
TABLE 71. List of primary sources, used in the study of global Pneumonia Therapeutics Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Pneumonia Therapeutics Market, research methodology
FIG 2. Global Pneumonia Therapeutics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Pneumonia Therapeutics Market, key trends 2021
FIG 5. Global Pneumonia Therapeutics Market, growth prospects 2022-2029
FIG 6. Global Pneumonia Therapeutics Market, porters 5 force model
FIG 7. Global Pneumonia Therapeutics Market, pest analysis
FIG 8. Global Pneumonia Therapeutics Market, value chain analysis
FIG 9. Global Pneumonia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Pneumonia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Pneumonia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Pneumonia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Pneumonia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Pneumonia Therapeutics Market, regional snapshot 2019 & 2029
FIG 15. North America Pneumonia Therapeutics Market 2019 & 2029 (USD Billion)
FIG 16. Europe Pneumonia Therapeutics Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Pneumonia Therapeutics Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Pneumonia Therapeutics Market 2019 & 2029 (USD Billion)
FIG 19. Global Pneumonia Therapeutics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Pneumonia Therapeutics Market, research methodology
FIG 2. Global Pneumonia Therapeutics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Pneumonia Therapeutics Market, key trends 2021
FIG 5. Global Pneumonia Therapeutics Market, growth prospects 2022-2029
FIG 6. Global Pneumonia Therapeutics Market, porters 5 force model
FIG 7. Global Pneumonia Therapeutics Market, pest analysis
FIG 8. Global Pneumonia Therapeutics Market, value chain analysis
FIG 9. Global Pneumonia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Pneumonia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Pneumonia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Pneumonia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Pneumonia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Pneumonia Therapeutics Market, regional snapshot 2019 & 2029
FIG 15. North America Pneumonia Therapeutics Market 2019 & 2029 (USD Billion)
FIG 16. Europe Pneumonia Therapeutics Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Pneumonia Therapeutics Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Pneumonia Therapeutics Market 2019 & 2029 (USD Billion)
FIG 19. Global Pneumonia Therapeutics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
